As part of an industry group visit to Russia last month, Hubertus Cranz, director of the European Proprietary Medicines Manufacturers' Association (AESGP), discussed international trends in pharmaceutical legislation with Russian health experts. The meeting was opened by former Prime Minister Gaydar and was chaired by Prof Deni-senko, chairlady of the Health Committee of the Russian Parliament.
The meeting was constructive and highly appreciated by the Russian participants, according to the AESGP, and for most attendees it provided them with their first opportunity to obtain information on international trends and to exchange views with an international audience.
Dr Cranz reports that much of the deliberation centered on the current considerations in the Russian Parliament on a new drug law, the first draft of which was voted down. The Committee is now working on modifications.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze